Truist Financial Corp Biogen Inc. Transaction History

Truist Financial Corp

$65 Billion
Q2 2024

A detailed history of Truist Financial Corp transactions in Biogen Inc. stock. As of the latest transaction made, Truist Financial Corp holds 39,669 shares of BIIB stock, worth $6.89 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

39,669

Previous 42,422 6.49%

Holding current value

$6.89 Million

Previous $9.15 Million 0.54%

% of portfolio

0.01%

Previous 0.01%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 20, 2024	SELL	$190.52 - $236.72 $524,501 - $651,690	-2,753 Reduced 6.49%	39,669 $9.2 Million
Q1 2024 May 10, 2024	BUY	$212.02 - $267.71 $107,494 - $135,728	507 Added 1.21%	42,422 $9.15 Million
Q4 2023 Feb 02, 2024	SELL	$222.59 - $267.94 $2.15 Million - $2.59 Million	-9,681 Reduced 18.76%	41,915 $10.8 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $4.47 Million - $5.05 Million	-17,656 Reduced 25.5%	51,596 $13.3 Million
Q2 2023 Aug 01, 2023	SELL	$275.25 - $318.06 $530,406 - $612,901	-1,927 Reduced 2.71%	69,252 $19.7 Million
Q1 2023 May 05, 2023	BUY	$256.56 - $292.34 $2.98 Million - $3.39 Million	11,605 Added 19.48%	71,179 $19.8 Million
Q4 2022 Feb 17, 2023	SELL	$252.44 - $306.72 $1.87 Million - $2.28 Million	-7,422 Reduced 11.08%	59,574 $16.5 Million
Q3 2022 Oct 26, 2022	BUY	$194.69 - $268.46 $2.51 Million - $3.46 Million	12,887 Added 23.82%	66,996 $17.9 Million
Q2 2022 Jul 22, 2022	SELL	$187.54 - $223.02 $1.83 Million - $2.18 Million	-9,760 Reduced 15.28%	54,109 $11 Million
Q1 2022 Apr 22, 2022	BUY	$193.77 - $244.14 $1.18 Million - $1.49 Million	6,105 Added 10.57%	63,869 $13.5 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $5.48 Million - $7.04 Million	-24,467 Reduced 29.75%	57,764 $13.9 Million
Q3 2021 Nov 05, 2021	SELL	$282.99 - $369.05 $72,162 - $94,107	-255 Reduced 0.31%	82,231 $23.3 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $314,944 - $504,287	1,216 Added 1.5%	82,486 $28.6 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $3.38 Million - $3.96 Million	13,914 Added 20.66%	81,270 $22.7 Million
Q4 2020 Nov 19, 2021	SELL	$236.26 - $355.63 $983,786 - $1.48 Million	-4,164 Reduced 5.82%	67,356 $16.5 Million
Q4 2020 Feb 18, 2021	SELL	$236.26 - $355.63 $958,270 - $1.44 Million	-4,056 Reduced 5.37%	71,520 $17.5 Million
Q3 2020 Nov 05, 2021	BUY	$264.77 - $305.71 $19,063 - $22,011	72 Added 0.1%	75,576 $21.4 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $10.2 Million - $11.8 Million	-38,479 Reduced 33.76%	75,504 $21.4 Million
Q2 2020 Nov 16, 2021	BUY	$258.66 - $342.55 $14,743 - $19,525	57 Added 0.05%	113,983 $30.5 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $3.45 Million - $4.56 Million	13,323 Added 13.24%	113,926 $30.5 Million
Q1 2020 Nov 05, 2021	BUY	$268.85 - $341.04 $15,324 - $19,439	57 Added 0.06%	100,603 $31.8 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $1.81 Million - $2.3 Million	6,749 Added 7.2%	100,546 $31.8 Million
Q4 2019 Nov 16, 2021	BUY	$220.06 - $304.07 $10,342 - $14,291	47 Added 0.05%	93,797 $27.8 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $15.7 Million - $21.7 Million	71,348 Added 318.49%	93,750 $27.8 Million
Q3 2019 Oct 31, 2019	SELL	$217.44 - $243.88 $60,448 - $67,798	-278 Reduced 1.23%	22,402 $5.22 Million
Q2 2019 Jul 24, 2019	SELL	$219.29 - $241.72 $60,962 - $67,198	-278 Reduced 1.21%	22,680 $5.31 Million
Q1 2019 Apr 23, 2019	BUY	$216.71 - $338.96 $294,292 - $460,307	1,358 Added 6.29%	22,958 $5.43 Million
Q4 2018 Jan 22, 2019	BUY	$278.5 - $352.75 $5.46 Million - $6.92 Million	19,615 Added 988.16%	21,600 $6.5 Million
Q3 2018 Oct 17, 2018	BUY	$293.51 - $383.83 $83,650 - $109,391	285 Added 16.76%	1,985 $701,000
Q2 2018 Jul 26, 2018	SELL	$257.52 - $306.91 $16,481 - $19,642	-64 Reduced 3.63%	1,700 $493,000
Q1 2018 Apr 20, 2018	SELL	$260.13 - $367.91 $19,249 - $27,225	-74 Reduced 4.03%	1,764 $483,000
Q4 2017 Jan 29, 2018	SELL	$307.64 - $344.58 $43,992 - $49,274	-143 Reduced 7.22%	1,838 $586,000
Q3 2017 Oct 23, 2017	BUY	$281.15 - $329.69 $556,958 - $653,115	1,981	1,981 $620,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Biogen Inc. Transaction History